HEAD AND NECK CANCERS
Clinical trials for HEAD AND NECK CANCERS explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK CANCERS trials appear
Sign up with your email to follow new studies for HEAD AND NECK CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug trial targets genetic weaknesses in tumors
Disease control Recruiting nowThis early-stage study is testing a new drug called IDE161, both alone and combined with an existing immunotherapy (pembrolizumab), for people with advanced solid tumors that have spread. The main goals are to find safe doses and see if the treatment shows early signs of shrinkin…
Matched conditions: HEAD AND NECK CANCERS
Phase: PHASE1 • Sponsor: IDEAYA Biosciences • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New pill targets tough cancers after other treatments fail
Disease control Recruiting nowThis early-stage study is testing a new oral drug called VMD-928, both by itself and combined with an existing immunotherapy (pembrolizumab). It is for adults with advanced solid tumors or lymphoma that have progressed despite available treatments. The main goals are to find safe…
Matched conditions: HEAD AND NECK CANCERS
Phase: PHASE1, PHASE2 • Sponsor: VM Oncology, LLC • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
First patients to receive new cancer drug in groundbreaking safety trial
Disease control Recruiting nowThis is the first-ever study in people for a new drug called EPI-326. It aims to find a safe dose and see how the body handles the drug in patients with advanced lung cancer (with a specific genetic change called EGFR mutation) or advanced head and neck cancer. The main goal is t…
Matched conditions: HEAD AND NECK CANCERS
Phase: PHASE1 • Sponsor: EpiBiologics • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Modified virus targets Hard-to-Treat cancers in groundbreaking trial
Disease control Recruiting nowThis first-in-human study is testing an experimental cancer treatment called IDOV-Immune, which uses a modified virus designed to infect and destroy cancer cells while boosting the immune system. The trial aims to find the safest dose and check for early signs that the treatment …
Matched conditions: HEAD AND NECK CANCERS
Phase: PHASE1 • Sponsor: ViroMissile, Inc. • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC
-
Researchers map the costly journey of facial reconstruction after cancer
Knowledge-focused Recruiting nowThis study aims to understand the full medical journey and costs for patients who need major facial reconstruction after head and neck cancer surgery. It will follow 200 patients in France for a year, tracking their hospital visits, treatments, medications, and quality of life. T…
Matched conditions: HEAD AND NECK CANCERS
Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC
-
Sharper scans for better cancer treatment?
Knowledge-focused Recruiting nowThis study is testing a new type of CT scanner called HyperSight, which is built into a radiation therapy machine. Researchers want to see if the clearer pictures it takes can help doctors plan and deliver radiation treatment more accurately for various cancers. They will compare…
Matched conditions: HEAD AND NECK CANCERS
Phase: NA • Sponsor: Varian, a Siemens Healthineers Company • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:19 UTC